These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21717139)

  • 1. The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats.
    Wen JH; Xiong YQ
    Eur J Drug Metab Pharmacokinet; 2011 Dec; 36(4):205-11. PubMed ID: 21717139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
    Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
    Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of herbal medicine ursolic acid on the uptake of rosuvastatin mediated by OATP1B1*1a and *5.
    Hua WJ; Hua WX; Nan FY; Jiang WA; Yan C
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):221-30. PubMed ID: 24736980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [OATP1B1 in drug-drug interactions between traditional Chinese medicine Danshensu and rosuvastatin].
    Wen JH; Wei XH; Cheng XH; Zuo R; Peng HW; Lü YN; Zhou J; Zheng XL; Cai J; Xiong YQ; Cao L
    Yao Xue Xue Bao; 2016 Jan; 51(1):75-9. PubMed ID: 27405165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
    Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
    Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin.
    Custodio JM; Wang H; Hao J; Lepist EI; Ray AS; Andrews J; Ling KH; Cheng A; Kearney BP; Ramanathan S
    J Clin Pharmacol; 2014 Jun; 54(6):649-56. PubMed ID: 24375014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin.
    Kitamura S; Maeda K; Wang Y; Sugiyama Y
    Drug Metab Dispos; 2008 Oct; 36(10):2014-23. PubMed ID: 18617601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1.
    Fan L; Zhang W; Guo D; Tan ZR; Xu P; Li Q; Liu YZ; Zhang L; He TY; Hu DL; Wang D; Zhou HH
    Clin Pharmacol Ther; 2008 Mar; 83(3):471-6. PubMed ID: 17851565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.
    Allred AJ; Bowen CJ; Park JW; Peng B; Williams DD; Wire MB; Lee E
    Br J Clin Pharmacol; 2011 Aug; 72(2):321-9. PubMed ID: 21434975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of silymarin supplement on the pharmacokinetics of rosuvastatin.
    Deng JW; Shon JH; Shin HJ; Park SJ; Yeo CW; Zhou HH; Song IS; Shin JG
    Pharm Res; 2008 Aug; 25(8):1807-14. PubMed ID: 18236139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transepithelial transport of rosuvastatin and effect of ursolic acid on its transport in Caco-2 monolayers.
    Hua WJ; Fang HJ; Hua WX
    Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):225-31. PubMed ID: 22562361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Na+/taurocholate cotransporting polypeptide (NTCP) c.800C > T polymorphism on rosuvastatin pharmacokinetics in Chinese healthy males.
    Lou XY; Zhang W; Wang G; Hu DL; Guo D; Tan ZR; Zhou HH; Chen Y; Bao HH
    Pharmazie; 2014 Oct; 69(10):775-9. PubMed ID: 25985569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of novel platelet-increasing agent eltrombopag with rosuvastatin via breast cancer resistance protein in humans.
    Takeuchi K; Sugiura T; Matsubara K; Sato R; Shimizu T; Masuo Y; Horikawa M; Nakamichi N; Ishiwata N; Kato Y
    Drug Metab Dispos; 2014 Apr; 42(4):726-34. PubMed ID: 24440960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine.
    Jamei M; Bajot F; Neuhoff S; Barter Z; Yang J; Rostami-Hodjegan A; Rowland-Yeo K
    Clin Pharmacokinet; 2014 Jan; 53(1):73-87. PubMed ID: 23881596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.
    Choi JH; Lee MG; Cho JY; Lee JE; Kim KH; Park K
    Clin Pharmacol Ther; 2008 Feb; 83(2):251-7. PubMed ID: 17568401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of OATP1B1 521T --> C heterogenesis on pharmacokinetic characterstics of rosuvastatin in Chinese volunteers].
    Sui SM; Wen JH; Li XH; Xiong YQ
    Yao Xue Xue Bao; 2011 Jun; 46(6):695-700. PubMed ID: 21882531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote.
    Wan Z; Wang G; Li T; Xu B; Pei Q; Peng Y; Sun H; Cheng L; Zeng Y; Yang G; Zhu YS
    J Pharmacol Exp Ther; 2015 Sep; 354(3):310-5. PubMed ID: 26081159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Ursolic Acid on Breast Cancer Resistance Protein-mediated Transport of Rosuvastatin In Vivo and Vitro.
    Wen JH; Wei XH; Sheng XY; Zhou DQ; Peng HW; Lu YN; Zhou J
    Chin Med Sci J; 2015 Dec; 30(4):218-25. PubMed ID: 26960302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.
    Simonson SG; Raza A; Martin PD; Mitchell PD; Jarcho JA; Brown CD; Windass AS; Schneck DW
    Clin Pharmacol Ther; 2004 Aug; 76(2):167-77. PubMed ID: 15289793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.
    Zhang W; Yu BN; He YJ; Fan L; Li Q; Liu ZQ; Wang A; Liu YL; Tan ZR; Fen-Jiang ; Huang YF; Zhou HH
    Clin Chim Acta; 2006 Nov; 373(1-2):99-103. PubMed ID: 16784736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.